<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01826929</url>
  </required_header>
  <id_info>
    <org_study_id>USI-10-66</org_study_id>
    <secondary_id>SM I 14/2010</secondary_id>
    <nct_id>NCT01826929</nct_id>
  </id_info>
  <brief_title>Effectiveness New Health Care Organization Model in Primary Care for Chronic Cardiovascular Disease Patients Based</brief_title>
  <acronym>PROPRESE</acronym>
  <official_title>Effectiveness of a New Health Care Organization Model in Primary Care for Chronic Cardiovascular Disease Patients Based on a Multifactorial Intervention: The PROPRESE Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a multifactorial primary care intervention
      based on chronic models can improve the level of control and reduce the number of hospital
      admissions in patients with ischemic heart disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Number of hospitalizations/cause at 12 months</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Blood pressure</measure>
    <time_frame>Baseline, 4 months, 8 months and 12 months.</time_frame>
    <description>It is measured at each visit in order to monitor the evolution. However, the change is calculated as the latest time point minus the earliest time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline LDL cholesterol</measure>
    <time_frame>Baseline, 4 months, 8 months and 12 months.</time_frame>
    <description>It is measured at each visit in order to monitor the evolution. However, the change is calculated as the latest time point minus the earliest time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Body Mass Index</measure>
    <time_frame>Baseline, 4 months, 8 months and 12 months</time_frame>
    <description>It is measured at each visit in order to monitor the evolution. However, the change is calculated as the latest time point minus the earliest time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Basal Blood Glucose</measure>
    <time_frame>Baseline, 4 months, 8 months and 12 months</time_frame>
    <description>It is measured at each visit in order to monitor the evolution. However, the change is calculated as the latest time point minus the earliest time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Healthy Life Habits (exercise, mediterranean diet)</measure>
    <time_frame>Baseline, 4 months, 8 months and 12 months</time_frame>
    <description>It is measured at each visit in order to monitor the evolution. However, the change is calculated as the latest time point minus the earliest time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Number of annual primary care visits</measure>
    <time_frame>Baseline and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Therapeutic education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Organized intervention strategy:Informed active patient, shared decision making, appointment planning, primary care doctor-nurse teamwork, actions based on scientific evidence.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care model</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic education</intervention_name>
    <arm_group_label>Therapeutic education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with a diagnosis of IHD of any site (ICD-10 codes from 410 to 414 inclusive.

          -  signed written informed consent

        Exclusion Criteria:

          -  lack of consent

          -  immobilized patients

          -  patients with serious health problems or with a low life expectancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Domingo Orozco-Beltran</last_name>
    <phone>0034 965919309</phone>
    <email>dorozcobeltran@hotmai.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>San Juan de Alicante</city>
        <state>Alicante</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domingo Orozco-Beltran</last_name>
      <phone>0034965919309</phone>
      <email>dorozcobeltran@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Domingo Orozco-Beltran</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Castellon</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Enrique Soler-Bahilo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jorge Navarro-Perez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Lorig KR, Ritter PL, Dost A, Plant K, Laurent DD, McNeil I. The Expert Patients Programme online, a 1-year study of an Internet-based self-management programme for people with long-term conditions. Chronic Illn. 2008 Dec;4(4):247-56. doi: 10.1177/1742395308098886.</citation>
    <PMID>19091933</PMID>
  </reference>
  <reference>
    <citation>Banegas JR, Rodríguez-Artalejo F, Graciani A, Villar F, Herruzo R. Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr. 2003 Sep;57 Suppl 1:S18-21.</citation>
    <PMID>12947446</PMID>
  </reference>
  <reference>
    <citation>Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007 Oct;28(19):2375-414. Epub 2007 Aug 28.</citation>
    <PMID>17726041</PMID>
  </reference>
  <reference>
    <citation>Lobos JM, Royo-Bordonada MA, Brotons C, Alvarez-Sala L, Armario P, Maiques A, Mauricio D, Sans S, Villar F, Lizcano A, Gil-Núñez A, de Alvaro F, Conthe P, Luengo E, Del Río A, Cortés O, de Santiago A, Varga MA, Martínez M, Lizarbe V; Comité Español Interdisciplinario para la Prevención Cardiovascular. [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation]. Rev Clin Esp. 2009 Jun;209(6):279-302. Spanish.</citation>
    <PMID>19635253</PMID>
  </reference>
  <reference>
    <citation>Selby JV, Schmittdiel JA, Fireman B, Jaffe M, Ransom LJ, Dyer W, Uratsu CS, Reed ME, Kerr EA, Hsu J. Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial. BMC Health Serv Res. 2012 Jul 2;12:183. doi: 10.1186/1472-6963-12-183.</citation>
    <PMID>22747998</PMID>
  </reference>
  <reference>
    <citation>Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.</citation>
    <PMID>19286092</PMID>
  </reference>
  <reference>
    <citation>Brotons C, Permanyer G, Pacheco V, Moral I, Ribera A, Cascant P, Pinar J; PREMISE study group. Prophylactic treatment after myocardial infarction in primary care: how far can we go? Fam Pract. 2003 Feb;20(1):32-5.</citation>
    <PMID>12509367</PMID>
  </reference>
  <reference>
    <citation>Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002 Oct 16;288(15):1909-14.</citation>
    <PMID>12377092</PMID>
  </reference>
  <reference>
    <citation>Davino-Ramaya C, Krause LK, Robbins CW, Harris JS, Koster M, Chan W, Tom GI. Transparency matters: Kaiser Permanente's National Guideline Program methodological processes. Perm J. 2012 Winter;16(1):55-62. Review.</citation>
    <PMID>22529761</PMID>
  </reference>
  <reference>
    <citation>Munoz MA, Vila J, Cabañero M, Rebato C, Subirana I, Sala J, Marrugat J; ICAR (Intervención en la Comunidad de Alto Riesgo cardiovascular) investigators. Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial. Int J Cardiol. 2007 Jun 12;118(3):312-20. Epub 2007 Jan 29.</citation>
    <PMID>17261336</PMID>
  </reference>
  <reference>
    <citation>Munoz MA, Rohlfs I, Masuet S, Rebato C, Cabañero M, Marrugat J; ICAR Study Group. Analysis of inequalities in secondary prevention of coronary heart disease in a universal coverage health care system. Eur J Public Health. 2006 Aug;16(4):361-7. Epub 2005 Oct 17.</citation>
    <PMID>16230314</PMID>
  </reference>
  <reference>
    <citation>Orozco-Beltrán D, Brotons C, Moral I, Soriano N, Del Valle MA, Rodríguez AI, Pepió JM, Pastor A; investigadores del estudio PREseAP. [Factors affecting the control of blood pressure and lipid levels in patients with cardiovascular disease: the PREseAP Study]. Rev Esp Cardiol. 2008 Mar;61(3):317-21. Spanish.</citation>
    <PMID>18361907</PMID>
  </reference>
  <reference>
    <citation>Brotons C, Soriano N, Moral I, Rodrigo MP, Kloppe P, Rodríguez AI, González ML, Ariño D, Orozco D, Buitrago F, Pepió JM, Borrás I; PREseAP study research team. Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study. Rev Esp Cardiol. 2011 Jan;64(1):13-20. doi: 10.1016/j.recesp.2010.07.005. Epub 2010 Dec 30. Erratum in: Rev Esp Cardiol. 2011 Jun;64(6):544.</citation>
    <PMID>21194823</PMID>
  </reference>
  <reference>
    <citation>Murphy AW, Cupples ME, Smith SM, Byrne M, Byrne MC, Newell J; SPHERE study team. Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial. BMJ. 2009 Oct 29;339:b4220. doi: 10.1136/bmj.b4220.</citation>
    <PMID>19875426</PMID>
  </reference>
  <reference>
    <citation>Ortiz Tobarra MT, Orozco Beltrán D, Gil Guillén V, Terol Moltó C. [Frequency of attendance and degree of control of type-2 diabetic patients]. Aten Primaria. 2008 Mar;40(3):139-44. Spanish.</citation>
    <PMID>18373926</PMID>
  </reference>
  <reference>
    <citation>Mira JJ, Orozco-Beltrán D, Pérez-Jover V, Martínez-Jimeno L, Gil-Guillén VF, Carratala-Munuera C, Sánchez-Molla M, Pertusa-Martínez S, Asencio-Aznar A. Physician patient communication failure facilitates medication errors in older polymedicated patients with multiple comorbidities. Fam Pract. 2013 Feb;30(1):56-63. doi: 10.1093/fampra/cms046. Epub 2012 Aug 17.</citation>
    <PMID>22904014</PMID>
  </reference>
  <reference>
    <citation>Márquez-Contreras E, de la Figuera-Von Wichmann M, Franch-Nadal J, Llisterri-Caro JL, Gil-Guillén V, Martín-de Pablos JL, Casado-Martínez JJ, Martell-Claros N. Do Patients With High Vascular Risk Take Antihypertensive Medication Correctly? Cumple-MEMS Study. Rev Esp Cardiol (Engl Ed). 2012 Jun;65(6):544-50. doi: 10.1016/j.recesp.2012.01.018. Epub 2012 Apr 19.</citation>
    <PMID>22520867</PMID>
  </reference>
  <reference>
    <citation>Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fernández S, González-Segura D, Carratalá-Munuera C, Martín de Pablo JL, Pallarés V, Pertusa-Martínez S, Fernández A, Redón J. Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging. 2011 Dec 1;28(12):981-92. doi: 10.2165/11596640-000000000-00000.</citation>
    <PMID>22117096</PMID>
  </reference>
  <reference>
    <citation>Gil-Guillén V, Orozco-Beltrán D, Pérez RP, Alfonso JL, Redón J, Pertusa-Martínez S, Navarro J, Cea-Calvo L, Quirce-Andrés F, Merino-Sánchez J, Carratalá C, Martín-Moreno JM. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press. 2010 Feb;19(1):3-10. doi: 10.3109/08037050903350762.</citation>
    <PMID>19929287</PMID>
  </reference>
  <reference>
    <citation>Clark CE, Smith LF, Taylor RS, Campbell JL. Nurse-led interventions used to improve control of high blood pressure in people with diabetes: a systematic review and meta-analysis. Diabet Med. 2011 Mar;28(3):250-61. doi: 10.1111/j.1464-5491.2010.03204.x. Review.</citation>
    <PMID>21309833</PMID>
  </reference>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2013</study_first_submitted>
  <study_first_submitted_qc>April 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2013</study_first_posted>
  <last_update_submitted>April 9, 2013</last_update_submitted>
  <last_update_submitted_qc>April 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Health Services Research</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Primary Care</keyword>
  <keyword>Secondary Prevention.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

